RxDoctor Payments Data

William Errico, DO

Family Medicine · Houston, MONPI 1366529570

Payments from drug & device makers

$313in general payments, 2019–2025

Across 17 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$62
  • Boehringer Ingelheim$43
  • Amgen$32
  • Lundbeck LLC$28
  • Neurocrine Biosciences, Inc.$22
  • GSK$18
  • plus $108 from 7 others

What the payments were for

  • Food & beverage$313100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$313 in reported general payments places this provider in the 45th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$31,950
Medicare patients
112
Services billed
347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol119$97,985
EliquisApixaban100$79,207
OzempicSemaglutide75$71,560
RybelsusSemaglutide24$33,433
JardianceEmpagliflozin22$30,885
VraylarCariprazine Hcl14$23,484
Breztri AerosphereBudesonide/Glycopyr/Formoterol31$22,276
JanuviaSitagliptin Phosphate18$20,863
MounjaroTirzepatide17$19,724
EntrestoSacubitril/Valsartan18$13,350
XareltoRivaroxaban20$12,319
SymbicortBudesonide/Formoterol Fumarate19$4,880
Pregabalin39$2,940
Albuterol Sulfate HfaAlbuterol Sulfate63$2,074
Modafinil15$1,860

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$14$125,142169 claims
Novo NordiskOzempic, Rybelsus$62$104,99399 claims
PfizerEliquis$13$79,207100 claims
Boehringer IngelheimJardiance$43$30,88522 claims
Lilly USA, LLCMounjaro$17$19,72417 claims
NovartisEntresto$16$13,35018 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Houston

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →